Company intelligence / Profile preview

USN

Midrand (Halfway House), Gauteng, South Africa

Ownership: Private
Employees: ~688
Development stage: Other

Overview

USN operates globally, distributing over 101 products focused on athletic performance, weight management, and muscle building, all currently marketed as commercial dietary supplements and tested for quality and safety but not as pharmaceuticals

Therapeutic areas: OtherEndocrinologyMen's Health
Modalities: Protein supplementsAmino acidsVitaminsSports nutrition blendsNot drug/biologic modalities
Industry: Food & Nutrition

Partnerships

Independent lab partnerships (for HFL Sports Science testing, compliant with WADA standard)uses independent manufacturers

Beyond the preview

Go deeper on USN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on USN.

Explore the full profile